General

Showing 2209–2224 of 2231 results

• 

  Article: VEXAS-syndrome: A state of the art

  €3.03 Only for registered clients
• 

  Article: Volume 6, Issue 1, February 2012

  €3.03 Only for registered clients
• 

  Article: Von Willebrand factor and ADAMTS13: new players in ischemia/reperfusion injury

  €3.03 Only for registered clients
• 

  Article: VON WILLEBRAND FACTOR: A NEW FLOW MARKER IN CARDIOVASCULAR PATHOLOGY

  €3.03 Only for registered clients
• 

  Article: Waldenstrom’s macroglobulinaemia: Belgian Hematology Society guidelines

  €3.03 Only for registered clients
• 

  Article: What about oligometastatic therapy in prostate cancer?

  €3.03 Only for registered clients
• 

  Article: What about oligometastatic therapy in prostate cancer?

  €3.03 Only for registered clients
• 

  Article: What About Oligometastatic Therapy In Prostate Cancer? Special,

  €3.03 Only for registered clients
• 

  Article: What can the tumour microenvironment tell us?

  €3.03 Only for registered clients
• 

  Article: What can the tumour microenvironment tell us?

  €3.03 Only for registered clients
• 

  Article: What do we still need to know about the treatment of RCC?

  €3.03 Only for registered clients
• 

  Article: What do we still need to know about the treatment of RCC?

  €3.03 Only for registered clients
• 

  Article: What Do We Still Need To Know About The Treatment Of Rcc? Special,

  €3.03 Only for registered clients
• 

  Article: What is new in MGUS and smoldering multiple myeloma

  €3.03 Only for registered clients
• 

  Article: What is your diagnosis?

  €3.03 Only for registered clients
• 

  Article: When is ponatinib a suitable treatment option for patients with chronic phase CML and how can we optimize the benefit/risk ratio?

  €3.03 Only for registered clients